Volterra is raising a CAD $2M–$2.5M seed round to accelerate commercial deployment of EVCare™ — the AI battery health intelligence platform built for the $32B EV fleet management market.
Investment Thesis
The EV fleet management market reaches $32B by 2030 at 22.7% CAGR. Government mandates for zero-emission public transit fleets by 2040 create non-discretionary spending at scale.
General telematics platforms offer surface-level battery metrics. No company delivers the depth of electrochemical intelligence EVCare™ provides — the category is wide open.
100+ white papers and 1,200+ provisional patent opportunities across 18 categories represent years of foundational R&D that cannot be quickly replicated by incumbents or new entrants.
Paid pilot programs with leading North American transit agencies. NRC IRAP grant funding. 28+ transit agencies assessed. The customer base is real and the problem is validated.
Ian McAvoy brings 30+ years across transportation and technology — including two decades as a transit and municipal executive operator in the UK and California, plus two prior cleantech ventures (GreenPower Motor Company and Thomson Power). This is a founder who has lived the problem from inside.
Use of Proceeds
Three clear value-creation pillars — each directly accelerating Volterra's path to recurring revenue and Series A readiness.
Convert active pilots with leading transit agencies to paid commercial contracts. Onboard 3–5 additional transit agency pilots across North America from the 28+ agency pipeline already developed.
~40%Accelerate EVCare™ v5.0 — completing the CareStar™ / BattHealthScore™ / FitStar™ three-layer architecture, hardening for enterprise deployment, and building the integrations large transit agencies require.
~35%Convert priority provisional patents to formal filings. Expand the team. Fund non-dilutive grant applications (Eureka Eurostars, BC Fast Pilot) targeting $4.6M–$9M in additional non-dilutive capital.
~25%Virtual Data Room
Select documents available on request. Full access provided to qualified investors following NDA execution.
Full investor presentation covering market opportunity, product architecture, traction, team, and financial projections.
Available on request28-agency product-market fit research, competitive landscape, and go-to-market strategy for North American transit.
Available on request3-year financial projections, revenue model, unit economics, and path to Series A milestones.
NDA requiredCurrent ownership structure, SAFE note details, secondary sale scenarios, and post-round pro forma capitalisation.
NDA required100+ white papers, 1,200+ provisional patent opportunities across 18 categories, and independent IP valuation assessment.
NDA requiredExecuted pilot program agreements with leading transit agencies and pipeline agencies. Letters of intent and commercial terms.
NDA requiredEVCare™ three-layer intelligence architecture, module specifications, and integration requirements documentation.
NDA requiredProposed four-entity structure, governance documents, and board composition.
Qualified investorsIntegrated Operating Plan v2.1 including staffing plan (20 positions), PMO scorecard, and 2026 commercial milestones.
Qualified investorsTraction & Validation
Paid pilot program with a major North American transit agency. Battery Electric Bus fleet. Full EVCare™ battery health monitoring and FitStar™ deployment.
Paid CommercialActive engagement with one of North America's largest transit authorities — for EVCare™ fleet intelligence evaluation.
ActiveNational Research Council IRAP grant funding secured — government validation of EVCare™'s technical innovation and commercial potential.
ValidatedActive R&D collaboration with BCIT supporting EVCare™ technical development and providing access to applied research and engineering talent.
ActiveIan McAvoy speaking at Electric Fleets USA 2026 in Los Angeles — positioning Volterra on stage at the premier North American fleet electrification conference.
September 2026Comprehensive product-market fit research across 28+ North American transit agencies before writing a single line of commercial code.
CompletedRequest Access
Complete the form to receive Volterra's investor materials. We respond within one business day with the appropriate documents for your stage of diligence.
Confidential · Accredited investors only · Vancouver, BC
Already an EVCare™ customer? Sign in to your portal →
Thank you for your interest. The Volterra team will be in touch within one business day with the appropriate materials.
Contact Ian McAvoy directly →